Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 513

    2.

    The diagnosis and management of pre-invasive breast disease--current challenges, future hopes.

    Lakhani SR.

    Breast Cancer Res. 2003;5(5):248-9. Epub 2003 Jul 28. Review. No abstract available.

    PMID:
    12927033
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    [Ductal hyperplasia and ductal carcinoma in situ. Definition--classification--differential diagnosis].

    Böcker W, Decker T, Ruhnke M, Schneider W.

    Pathologe. 1997 Jan;18(1):3-18. Review. German.

    PMID:
    9157402
    [PubMed - indexed for MEDLINE]
    5.

    Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.

    Bofin AM, Lydersen S, Hagmar BM.

    Diagn Cytopathol. 2004 Oct;31(4):207-15.

    PMID:
    15452908
    [PubMed - indexed for MEDLINE]
    6.

    The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ.

    Simpson PT, Gale T, Fulford LG, Reis-Filho JS, Lakhani SR.

    Breast Cancer Res. 2003;5(5):258-62. Epub 2003 Jul 29. Review.

    PMID:
    12927036
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    Comparative features of carcinoma in situ and atypical ductal hyperplasia of the breast on fine-needle aspiration biopsy specimens.

    Abendroth CS, Wang HH, Ducatman BS.

    Am J Clin Pathol. 1991 Nov;96(5):654-9.

    PMID:
    1659182
    [PubMed - indexed for MEDLINE]
    8.

    Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.

    Xu S, Wei B, Zhang H, Qing M, Bu H.

    Oncol Rep. 2008 Jun;19(6):1469-75.

    PMID:
    18497952
    [PubMed - indexed for MEDLINE]
    9.

    [Differential atypical ductal hyperplasia/DCIS/invasive carcinoma diagnosis and significance of micrometastases].

    Stosiek P.

    Zentralbl Chir. 1998;123 Suppl 5:13. German.

    PMID:
    10063563
    [PubMed - indexed for MEDLINE]
    10.

    [Usual hyperplasia, atypical hyperplasia and carcinoma-in-situ of breast: a morphologic study].

    Kan X, Shen DH, Shi B, He JS.

    Zhonghua Bing Li Xue Za Zhi. 2004 Aug;33(4):312-5. Chinese.

    PMID:
    15363313
    [PubMed - indexed for MEDLINE]
    11.

    Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.

    Adepoju LJ, Symmans WF, Babiera GV, Singletary SE, Arun B, Sneige N, Pusztai L, Buchholz TA, Sahin A, Hunt KK, Meric-Bernstam F, Ross MI, Ames FC, Kuerer HM.

    Cancer. 2006 Jan 1;106(1):42-50.

    PMID:
    16333852
    [PubMed - indexed for MEDLINE]
    Free Article
    12.

    Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6.

    Rabban JT, Koerner FC, Lerwill MF.

    Hum Pathol. 2006 Jul;37(7):787-93. Epub 2006 May 26.

    PMID:
    16784976
    [PubMed - indexed for MEDLINE]
    13.

    Update on atypical epithelial hyperplasia and ductal carcinoma in situ.

    Simpson JF.

    Pathology. 2009 Jan;41(1):36-9. Review.

    PMID:
    19089738
    [PubMed - indexed for MEDLINE]
    14.

    Atypical ductal hyperplasia and ductal carcinoma in situ of the breast associated with perineural invasion.

    Gobbi H, Jensen RA, Simpson JF, Olson SJ, Page DL.

    Hum Pathol. 2001 Aug;32(8):785-90.

    PMID:
    11521220
    [PubMed - indexed for MEDLINE]
    15.

    Nuclear cytometric changes in breast carcinogenesis.

    Mommers EC, Poulin N, Sangulin J, Meijer CJ, Baak JP, van Diest PJ.

    J Pathol. 2001 Jan;193(1):33-9.

    PMID:
    11169513
    [PubMed - indexed for MEDLINE]
    16.

    [Classification of preinvasive breast and carcinoma in situ: doubts, controversies, and proposal for new categorizations].

    Dauplat MM, Penault-Llorca F.

    Bull Cancer. 2004 Dec 1;91 Suppl 4:S205-10. Review. French.

    PMID:
    15899609
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    [Role of cytokeratin expression in differential diagnosis of intraductal proliferative lesions of breast].

    Zhang JL, Zhang HY, Wei B, Lang ZQ, Bu H.

    Zhonghua Bing Li Xue Za Zhi. 2004 Aug;33(4):316-9. Chinese.

    PMID:
    15363314
    [PubMed - indexed for MEDLINE]
    18.

    Stereotactic vacuum-assisted breast biopsy in 268 nonpalpable lesions.

    Tonegutti M, Girardi V.

    Radiol Med. 2008 Feb;113(1):65-75. Epub 2008 Feb 25. English, Italian.

    PMID:
    18338128
    [PubMed - indexed for MEDLINE]
    19.

    Assessment of lesions coexisting with various grades of ductal intraepithelial neoplasia of the breast.

    Bratthauer GL, Tavassoli FA.

    Virchows Arch. 2004 Apr;444(4):340-4. Epub 2004 Feb 19.

    PMID:
    14986131
    [PubMed - indexed for MEDLINE]
    20.

    The diagnosis and management of pre-invasive breast disease: problems associated with management of pre-invasive lesions.

    Purushotham AD.

    Breast Cancer Res. 2003;5(6):309-12. Epub 2003 Oct 9. Review.

    PMID:
    14580248
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk